Journal ArticleOPEN ACCESS

Soluble IL‐2R: A potential therapeutic target for mitochondrial dysfunction in post‐COVID fatigue syndrome

  • Brown L
  • Joshi J
  • Kosmac K
  • et al.
Clinical and Translational Medicine (2025) 15(10)
DOI: 10.1002/ctm2.70507
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Brown, L. P., Joshi, J., Kosmac, K., Long, D. E., Scott, L., El‐Amouri, S., … Wen, Y. (2025). Soluble IL‐2R: A potential therapeutic target for mitochondrial dysfunction in post‐COVID fatigue syndrome. Clinical and Translational Medicine, 15(10). https://doi.org/10.1002/ctm2.70507

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free